Skip to content

Multicentre Clinical Trial. Project EXIMe

Effectiveness of a Sexual Health Intervention in Women With Genitourinary Syndrome of Menopause to Improve Their Quality of Life. Multicentre Clinical Trial. Project EXIMe

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03558451
Acronym
EXIMe
Enrollment
250
Registered
2018-06-15
Start date
2017-07-10
Completion date
2019-03-15
Last updated
2022-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Primary health care

Brief summary

Objective: to evaluate the effectiveness of an individualized intervention in sexual health conducted in the midwife consultation to improve the quality of life in women with Genitourinary Syndrome of Menopause. Design: Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid.

Detailed description

Genitourinary Syndrome of Menopause is a common condition that increases by four the risk of having a sexual dysfunction, and that affects the quality of life of women who suffer it. Those women with an active sexual life have fewer symptoms associated with this syndrome. Objective: to evaluate the effectiveness of an individualized intervention in sexual health conducted in the midwife consultation to improve the quality of life in women with Genitourinary Syndrome of Menopause. Design: Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid. Population: women aged between 45-65 years with Genitourinary Syndrome of Menopause attending to the midwife consultation. N= 250 (125 women in each group) will be included by midwifes in the Primary Health Care consultations in the Community of Madrid. Control group: women will receive the usual assistance. Experimental group: in addition to the usual assistance, women will receive a complex intervention in sexual health, individualized, in the midwife consultation, where techniques for expression, analysis, information and development of sexual health skills will be used. Variables: Main-Quality of life in menopause (measured with the Cervantes Short-Form Scale). Secondary- sociodemographic variables, sexual history and variables related to the Genitourinary Syndrome of Menopause. Analysis: by intention-to-treat, comparing the quality of life in menopause scores before/after the intervention in both groups after 0, 1 and 6 months. To explain the factors associated with a higher quality of life, a linear regression model would be fitted.

Interventions

OTHERComplex intervention in sexual health

EXIMe is a complex intervention in sexual health, individualized, in the midwife consultation, where techniques for expression, analysis, information and development of sexual health skills will be used.

OTHERUsual care

According to available protocols applicable to the patient and the health service standardized portfolio

Sponsors

Fundación de Innovación e Investigación Biomédica de Atención Primaria-Madrid
CollaboratorUNKNOWN
Gerencia de Atención Primaria, Madrid
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Only primary care midwives know and apply the intervention

Intervention model description

Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* women aged between 45-65 years with Genitourinary Syndrome of Menopause

Exclusion criteria

* women who present pathologies that lead to an alteration of sexual desire * women who receive or have received in the last six months treatment that increase the incidence of vaginal atrophy * women who receive or have received local hormonal therapy during the last month, systemic hormonal therapy in the last six months, or other systemic treatment for the Genitourinary Syndrome of Menopause * women who could not read or write, and not understand the spanish language.

Design outcomes

Primary

MeasureTime frameDescription
Main-Quality of life in menopauseChange from baseline Quality of life at six monthsMain-Quality of life in menopause measured with Cervantes Short-Form Scale (20 -100 points)

Secondary

MeasureTime frameDescription
Sexual functionChange from baseline at six monthsSexual function: measured with Questionnaire Health and female sexual dysfunction in primary care
vaginal pHChange from baseline at six monthsvaginal pH
Oxford scaleChange from baseline at six monthsOxford scale: pelvic floor muscle response
Urine sedimentChange from baseline at six monthsUrine sediment

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026